000 nab a22 7a 4500
999 _c18007
_d18007
003 PC18007
005 20250627131919.0
008 250627b xxu||||| |||| 00| 0 eng d
040 _cH12O
041 _aeng
100 _91906
_aSánchez Aragó, María
_eInstituto de Investigación i+12
245 0 0 _aMitochondrial response to the BCKDK-deficiency: Some clues to understand the positive dietary response in this form of autism.
_h[artículo]
260 _bBiochimica et biophysyca acta,
_c2016
300 _a1862(4):592-600.
500 _aFormato Vancouver: Oyarzabal A, Bravo Alonso I, Sánchez Aragó M, Rejas MT, Merinero B, García Cazorla A et al. Mitochondrial response to the BCKDK-deficiency: Some clues to understand the positive dietary response in this form of autism. Biochim Biophys Acta. 2016 Apr;1862(4):592-600.
501 _aPMID: 26809120.
504 _aContiene 39 referencias
520 _aMutations on the mitochondrial-expressed Branched Chain α-Keto acid Dehydrogenase Kinase (BCKDK) gene have been recently associated with a novel dietary-treatable form of autism. But, being a mitochondrial metabolism disease, little is known about the impact on mitochondrial performance. Here, we analyze the mitochondrial response to the BCKDK-deficiency in patient's primary fibroblasts by measuring bioenergetics, ultra-structural and dynamic parameters. A two-fold increase in superoxide anion production, together with a reduction in ATP-linked respiration and intracellular ATP levels (down to 60%) detected in mutants fibroblasts point to a general bioenergetics depletion that could affect the mitochondrial dynamics and cell fate. Ultrastructure analysis of BCKDK-deficient fibroblasts shows an increased number of elongated mitochondria, apparently associated with changes in the mediator of inner mitochondria membrane fusion, GTPase OPA1 forms, and in the outer mitochondrial membrane, mitofusin 2/MFN2. Our data support a possible hyperfusion response of BCKDK-deficient mitochondria to stress. Cellular fate also seems to be affected as these fibroblasts show an altered proportion of the cells on G0/G1 and G2/M phases. Knockdown of BCKDK gene in control fibroblasts recapitulates most of these features. Same BCKDK-knockdown in a MSUD patient fibroblasts unmasks the direct involvement of the accelerated BCAAs catabolism in the mitochondrial dysfunction. All these data give us a clue to understand the positive dietary response to an overload of branched-chain amino acids. We hypothesize that a combination of the current therapeutic option with a protocol that considers the oxidative damage and energy expenditure, addressing the patients' individuality, might be useful for the physicians.
710 _9625
_aInstituto de Investigación imas12
856 _uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/1/pc18007.pdf
_ySolicitar documento
942 _2ddc
_cART
_n0